Maxigen Biotech Inc. (TPE:1783)
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST
Maxigen Biotech Revenue
Maxigen Biotech had revenue of 220.38M TWD in the quarter ending September 30, 2026, with 9.72% growth. This brings the company's total for the last twelve months to 856.96M, up 8.14% year-over-year. In the year 2025, Maxigen Biotech had annual revenue of 811.56M with 19.23% growth. That makes Maxigen Biotech the 32,314th largest company in the world by revenue and 1,670th in Taiwan.
Revenue (ttm)
856.96M
Revenue Growth
+8.14%
P/S Ratio
3.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.85B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Maxigen Biotech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 811.56M | 130.91M | 19.23% |
| Dec 31, 2024 | 680.65M | 58.54M | 9.41% |
| Dec 31, 2023 | 622.12M | 17.68M | 2.93% |
| Dec 31, 2022 | 604.43M | 92.46M | 18.06% |
| Dec 31, 2021 | 511.98M | 54.29M | 11.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| Formosa Optical Technology | 4.46B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Nang Kuang Pharmaceutical | 2.09B |
| Bionime | 1.73B |
| Chi Sheng Pharma & Biotech | 1.43B |
| ICARES Medicus | 1.31B |